Ontology highlight
ABSTRACT: Introduction
The existence of an osteoporosis treatment gap, defined as the percentage of patients at risk for osteoporotic fractures exceeding an intervention threshold but remaining untreated, is widely acknowledged. Between 1998 and 2018, new bone active substances (BAS) indicated for the treatment of osteoporosis became available. Whether and if so to what extent these new introductions have altered the treatment gap is unknown.Met
SUBMITTER: Lippuner K
PROVIDER: S-EPMC9845158 | biostudies-literature | 2023 Jan
REPOSITORIES: biostudies-literature